Expression of the microRNA regulators Drosha, Dicer and Ago2 in non-small cell lung carcinomas

Cellular Oncology

Volumn 38, Issue 4, 2015, Pages 307-317

  Prodromaki, E ^a   Korpetinou, A ^a,b   Giannopoulou, E ^a,b   Vlotinou, E ^a   Chatziathanasiadou, Mu ^a   Papachristou, N I ^a   Scopa, C D ^a   Papadaki, H ^a   Kalofonos, H P ^a,b   Papachristou, D J ^a,c  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Ago2; Dicer; Drosha; Lung cancer; microRNA

Indexed keywords

ARGONAUTE 2 PROTEIN; DICER; DROSHA PROTEIN; FORMALDEHYDE; MESSENGER RNA; MICRORNA; PARAFFIN; REGULATOR PROTEIN; UNCLASSIFIED DRUG; ARGONAUTE PROTEIN; DEAD BOX PROTEIN; DICER1 PROTEIN, HUMAN; DROSHA PROTEIN, HUMAN; EIF2C2 PROTEIN, HUMAN; RIBONUCLEASE III;

ADULT; AGED; ARTICLE; CELLULAR DISTRIBUTION; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; NON SMALL CELL LUNG CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL LUNG CARCINOMA; WESTERN BLOTTING; ANALYSIS OF VARIANCE; CANCER GRADING; CANCER STAGING; CONFOCAL MICROSCOPY; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; METABOLISM; PATHOLOGY; SMALL CELL LUNG CANCER; TUMOR CELL LINE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ARGONAUTE PROTEINS; BLOTTING, WESTERN; CELL LINE, TUMOR; DEAD-BOX RNA HELICASES; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MICRORNAS; MICROSCOPY, CONFOCAL; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBONUCLEASE III; SMALL CELL LUNG CARCINOMA;

EID: 84938505310     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-015-0231-y     Document Type: Article

References (49)

1. Α. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, D. Forman, Global cancer statistics. CA Cancer J. Clin. 61, 69–90 (2011)
2. A. Koren, H. Motaln, T. Cufer, Lung cancer stem cells: a biological and clinical perspective. Cell. Oncol. 36, 265–275 (2013)
3. H. Peng, J. Huang, Y. Hu, Y. Wei, H. Liu, M. Huang, L. Wang, J. Wang, Associations between polymorphisms in the SYK promoter and susceptibility to sporadic colorectal cancer in a Southern Han Chinese population - a short report. Cell. Oncol. 38, 165–172 (2015)
4. E. Yiannakopoulou, Targeting epigenetic mechanisms and microRNAs by aspirin and other non steroidal anti-inflammatory agents—implications for cancer treatment and chemoprevention. Cell. Oncol. 37, 167–178 (2014)
5. B.P. Lewis, C.B. Burge, D.P. Bartel, Conserved seed pairing often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 14, 15–20 (2005)
6. R.C. Friedman, K.K. Farh, C.B. Burge, D.P. Bartel, Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19, 92–105 (2009)
7. L.P. Lim, N.C. Lau, P. Garrett-Engele, A. Grimson, J.M. Schelter, J. Castle, D.P. Bartel, P.S. Linsley, J.M. Johnson, Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433, 769–773 (2005)
8. D.J. Papachristou, E. Sklirou, D. Corradi, C. Crassani, V. Kontogeorgakos, U.N.M. Rao, Immunohistochemical analysis of the endoribonucleases Drosha, Dicer and Ago2 in smooth muscle tumours of soft tissues. Histopathology 60, E28–E36 (2012)
9. M. Negrini, M.S. Nicoloso, G.A. Calin, MicroRNAs and cancer: new paradigms in molecular oncology. Curr. Opin. Cell Biol. 21, 470–479 (2009)
10. T.A. Farazi, J.I. Spitzer, P. Morozov, T. Tuschl, microRNAs in human cancer. J. Pathol. 223, 102–115 (2011)
11. Y. Wang, H.M. Stricker, D. Gou, L. Liu, MicroRNA: past and present. Front. Biosci. 12, 2316–2329 (2007)
12. Y. Lee, C. Ahn, J. Han, H. Choi, J. Kim, J. Lee, P. Provost, O. Radmark, S. Kim, V.N. Kim, The nuclear RNase III Drosha initiates microRNA processing. Nature 425, 415–419 (2003)
13. L. Rask, E. Balslev, R. Søkilde, E. Høgdall, H. Flyger, J. Eriksen, T. Litman, Differential expression of miR-139, miR-486 and miR-21 in breast cancer patients sub-classified according to lymph node status. Cell. Oncol. 37, 215–227 (2014)
14. E. Lund, S. Guttinger, A. Calado, J.E. Dahlberg, U. Kutay, Nuclear export of microRNA precursors. Science 303, 95–98 (2004)
15. J. Mattes, A. Collison, P.S. Foster, Emerging role of microRNAs in disease pathogenesis and strategies for therapeutic modulation. Curr. Opin. Mol. Ther. 10, 150–157 (2008)
16. H. Guo, N.T. Ingolia, J.S. Weissman, D.P. Bartel, Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466, 835–840 (2010)
17. T. Tomankova, M. Petrek, E. Kriegova, Involvement of microRNAs in physiological and pathological processes in the lung. Respir. Res. 11, 159 (2010)
18. L. Peters, G. Meister, Argonaute proteins: mediators of RNA silencing. Mol. Cell 26, 611–623 (2007)
19. Y. Karube, H. Tanaka, H. Osada, Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci. 96, 111–115 (2005)
20. S. Chiosea, E. Jelezcova, U. Chandran, J. Luo, G. Mantha, R.W. Sobol, S. Dacic, Overexpression of Dicer in precursor lesions of lung adenocarcinoma. Cancer Res. 67, 2345–2350 (2007)
21. D.J. Papachristou, A. Korpetinou, E. Giannopoulou, A.G. Antonakopoulou, H. Papadaki, P. Grivas, C.D. Scopa, H.P. Kalofonos, Expression of the ribonucleases Drosha, Dicer, and Ago2 in colorectal carcinomas. Virchows Arch. 459, 431–440 (2011)
22. S.M. Jafarnejad, C. Sjoestroem, M. Martinka, G. Li, Expression of the RNase III enzyme DROSHA is reduced during progression of human cutaneous melanoma. Mod. Pathol. 26, 902–910 (2013)
23. S.M. Khoshnaw, E.A. Rakha, T. Abdel-Fatah, C.C. Nolan, Z. Hodi, R.D. Macmillan, I.O. Ellis, A.R. Green, The MicroRNA maturation regulator Drosha is an independent predictor of outcome in breast cancer patients. Breast Cancer Res. Treat. 137, 139–153 (2013)
24. K.J. Dedes, R. Natrajan, M.B. Lambros, F.C. Geyer, M.A. Lopez-Garcia, K. Savage, R.L. Jones, J.S. Reis-Filho, Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer. Eur. J. Cancer 47, 138–150 (2011)
25. N. Sugito, H. Ishiguro, Y. Kuwabara, M. Kimura, A. Mitsui, H. Kurehara, T. Ando, R. Mori, N. Takashima, R. Ogawa, Y. Fujii, RNASEN regulates cell proliferation and affects survival in esophageal cancer patients. Clin. Cancer Res. 12, 7322–7328 (2006)
26. S. Chiosea, E. Jelezcova, U. Chandran, M. Acquafondata, T. McHale, R.W. Sobol, R. Dhir, Up-regulation of Dicer, a component of the micro RNA machinery, in prostate adenocarcinoma. Am. J. Pathol. 169, 1812–1820 (2006)
27. R.J. Flavin, P.C. Smyth, S.R. Finn, A. Laios, S.A. O’ Toole, C. Barrett, M. Ring, K.M. Denning, J. Li, S.T. Aherne, N.A. Aziz, A. Alhadi, B.L. Sheppard, M. Loda, C. Martin, O.M. Sheils, J.J. O’ Leary, Altered eIF6 and Dicer expression is associated with clinicopathological features in ovarian serous carcinoma patients. Mod. Pathol. 21, 676–684 (2008)
28. C. Faber, D. Horst, F. Hlubek, T. Kirchner, Overexpression of Dicer predicts poor survival in colorectal cancer. Eur. J. Cancer 47, 1414–1419 (2011)
29. D.J. Papachristou, U.N.M. Rao, A. Korpetinou, E. Giannopoulou, E. Sklirou, V. Kontogeorgakos, H.P. Kalofonos, Dicer expression in sarcomas prognostic significance of dicer cellular levels in soft tissue sarcomas. Cancer Investig. 30, 172–179 (2011)
30. N. Potenza, U. Papa, A. Russo, Differential expression of Dicer and Argonaute genes during the differentiation of human neuroblastoma cells. Cell Biol. Int. 33, 734–738 (2009)
31. N. Potenza, U. Papa, P. Scaruffi, N. Mosca, G.P. Tonini, A. Russo, A novel splice variant of the human dicer gene is expressed in neuroblastoma cells. FEBS Lett. 584, 3452–3457 (2010)
32. W.M. Merrit, Y.G. Lin, L.Y. Han, A.A. Karnat, W.A. Spannuth, R. Schumandt, D. Urbauer, L.A. Pennacchio, J.F. Cheng, A.M. Nick, M.T. Deavers, A. Mourad- Zeidan, H. Wang, P. Mueller, M.E. Lenburg, J.W. Gray, S. Mok, M.J. Birrer, G. Lopez-Berestein, R.L. Coleman, M. Bar-Eli, A.K. Sood, Dicer, Drosha and outcomes in patients with ovarian cancer. N. Engl. J. Med. 359, 2641–2650 (2008)
33. W.D. Travis, E. Brambilla, H.K. Müller-Hermelink, C.C. Harris, Pathology and genetics of tumours of the lung, pleura, thymus and heart (IARC Press, Lyon, 2004), pp. 10–11
34. A.E. Williams, S.A. Moschos, M.M. Perry, P.J. Barnes, M.A. Lindsay, Maternally imprinted microRNAs are differentially expressed during mouse and human lung development. Dev. Dyn. 236, 572–580 (2007)
35. C. Chen, H. Chen, J. Sun, P. Jr, Y. Bringas, D. Chen, W.S. Warburton, Smad1 expression and function during mouse embryonic lung branching morphogenesis. Am. J. Physiol. Lung Cell. Mol. Physiol. 288, 1033–1039 (2005)
36. D.B. Frank, A. Abtahi, D.J. Yamaguchi, S. Manning, Y. Shyr, A. Pozzi, H.S. Baldwin, J.E. Johnson, M.P. de Caestecker, Bone morphogenetic protein 4 promotes pulmonary vascular remodeling in hypoxic pulmonary hypertension. Circ. Res. 97, 496–504 (2005)
37. Y. Lu, J.M. Thomson, H.Y. Wong, S.M. Hammond, B.L. Hogan, Transgenic overexpression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells. Dev. Biol. 310, 442–453 (2007)
38. Y. Li, E.Y. Chan, J. Li, C. Ni, X. Peng, E. Rosenzweig, T.M. Tumpey, M.G. Katze, MicroRNA expression and virulence in pandemic influenza virus-infected mice. J. Virol. 84, 3023–3032 (2010)
39. S. Volinia, G.A. Calin, C.G. Liu, S. Ambs, A. Cimmino, F. Petrocca, R. Visone, M. Iorio, C. Roldo, M. Ferracin, R.L. Prueitt, N. Yanaihara, G. Lanza, A. Scarpa, A. Vecchione, M. Negrini, C.C. Harris, C.M. Croce, A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U. S. A. 103, 2257–2261 (2006)
40. X. Tang, Y. Zhang, L. Tucker, B. Ramratnam, Phosphorylation of the RNase III enzyme Drosha at Serine 300 or Serine 302 is required for its nuclear localization. Nucleic Acids Res. 38, 6610–6619 (2010)
41. M.M. Bjaanae, A.R. Halvorsen AR, S. Solberg, L. Jørgensen, T.A. Dragani, A. Galvan, F. Colombo, M. Anderlini, U. Pastorino, E. Kure, A.L. Børresen-Dale, O.T. Brustugun, A. Helland, Unique microRNA-profiles in EGFR-mutated lung adenocarcinomas. Int. J. Cancer 135, 1812–1821 (2014)
42. S. Hong, H. Noh, H. Chen, R. Padia, Z.K. Pan, S.B. Su, Q. Jing, H.F. Ding, S. Huang, Signaling by p38 MAPK stimutaltes nuclear localization of the microprocessor component p68 for processing of selected primary MicroRNAs. Sci. Signal. 6, ra16 (2013)
43. C.V. Diaz-Garcia, A. Agudo-Lopez, C. Perez, A. Lopez-Martin, J.L. Rodriguez-Peralt, J. de Castro, A. Cortijo, M. Martinez-Villanueva, L. Iglesias, Dicer1, Drosha and miRNAs in patients with non-small cell lng cancer: implications for outcomes and histologic classification. Carcinogenesis 34, 1031–1038 (2013)
44. G. Grelier, N. Voirin, A.S. Ay, D.G. Cox, S. Chabaud, I. Treilleux, S. Leon-Goddard, R. Rimokh, I. Mikaelian, C. Venoux, A. Puisieux, C. Lasset, C. Moyret-Lalle, Prognostic value of Dicer in human breast cancers and association with the mesenchymal phenotype. Br. J. Cancer 101, 673–683 (2009)
45. X. Zhang, P. Graves, Y. Zeng, Overexpression of human Argonaute2 inhibits cell and tumor growth. Biochim. Biophys. Acta 1830, 2553–2561 (2013)
46. J. Zhang, X.S. Fan, C.X. Wang, B. Liu, Q. Li, X.J. Zhou, Up-regulation of Ago2 expression in gastric carcinoma. Med. Oncol. 30, 628 (2013)
47. A.M. Liu, C. Zhang, J. Burchard, S.T. Fan, K.F. Wong, H. Dai, R.T. Poon, J.M. Luk, Global regulation on microRNA in hepatitis B virus-associated hepatocellular carcinoma. OMICS 15, 187–191 (2011)
48. B.D. Adams, K.P. Claffey, B.A. White, Argonaute-2 expression is regulated by epidermal growth factor receptor and mitogen-activated protein kinase signaling and correlates with a transformed phenotype in breast cancer cells. Endocrinology 150, 14–23 (2009)
49. S.H. Ahn, E.H. Jeong, T.G. Lee, S.Y. Kim, H.R. Kim, C.H. Kim, Gefitinib induces cytoplasmic translocation of the CDK inhibitor p27 and its binding to a cleaved intermediate of caspase 8 in non-small cell lung cancer cells. Cell. Oncol. 37, 377–386 (2014)